<div class="infobox infobox-protein">
| | |
|---|---|
| Protein Name | Neuregulin-3 (NRG3) |
| Gene | [NRG3](/genes/nrg3) |
| UniProt ID | [Q9UHD8](https://www.uniprot.org/uniprot/Q9UHD8) |
| Molecular Weight | ~82 kDa (full-length); ~40 kDa (processed) |
| Subcellular Localization | Plasma membrane, secreted |
| Protein Family | Neuregulin family |
| Chromosomal Location | 10p12.31 |
| Brain Expression | Cortex, Hippocampus, Thalamus, Substantia nigra |
</div>
Neuregulin-3 (NRG3) is a member of the neuregulin family of growth factors that signal through ErbB receptor tyrosine kinases. Unlike other neuregulin family members (NRG1, NRG2), NRG3 exhibits unique expression patterns and signaling properties that suggest specialized functions in neural development, synaptic plasticity, and cognitive function[@zhang2004][@woolard2007].
The neuregulin family consists of six structurally related proteins (NRG1-NRG6) that are characterized by an epidermal growth factor (EGF)-like domain responsible for receptor binding. NRG3 is encoded by the NRG3 gene on chromosome 10p12.31 and undergoes alternative splicing to generate multiple isoforms with distinct functional properties[@falls2003].
<div class="infobox infobox-protein">
| | |
|---|---|
| Protein Name | Neuregulin-3 (NRG3) |
| Gene | [NRG3](/genes/nrg3) |
| UniProt ID | [Q9UHD8](https://www.uniprot.org/uniprot/Q9UHD8) |
| Molecular Weight | ~82 kDa (full-length); ~40 kDa (processed) |
| Subcellular Localization | Plasma membrane, secreted |
| Protein Family | Neuregulin family |
| Chromosomal Location | 10p12.31 |
| Brain Expression | Cortex, Hippocampus, Thalamus, Substantia nigra |
</div>
Neuregulin-3 (NRG3) is a member of the neuregulin family of growth factors that signal through ErbB receptor tyrosine kinases. Unlike other neuregulin family members (NRG1, NRG2), NRG3 exhibits unique expression patterns and signaling properties that suggest specialized functions in neural development, synaptic plasticity, and cognitive function[@zhang2004][@woolard2007].
The neuregulin family consists of six structurally related proteins (NRG1-NRG6) that are characterized by an epidermal growth factor (EGF)-like domain responsible for receptor binding. NRG3 is encoded by the NRG3 gene on chromosome 10p12.31 and undergoes alternative splicing to generate multiple isoforms with distinct functional properties[@falls2003].
NRG3 primarily signals through the ErbB4 receptor, although it can also bind to other ErbB family members with lower affinity. In the central nervous system, NRG3 is expressed in specific neuronal populations and regulates critical developmental processes including cortical patterning, GABAergic circuit formation, myelination, and synaptic plasticity. Notably, NRG3 has been strongly implicated in schizophrenia pathogenesis, with genetic association studies identifying multiple risk variants[@anton2004][@buonanno2012].
The human NRG3 gene spans approximately 1.1 Mb on chromosome 10p12.31 and contains 20 exons. The gene produces multiple isoforms through alternative splicing, including:
NRG3 contains several distinctive structural features:
N-terminal Signal Peptide (aa 1-20): Directs secretion to the endoplasmic reticulum and Golgi apparatus.
Immunoglobulin-like Domain (aa 60-200): Present in type I NRG3, mediates interaction with extracellular matrix and presentation of the EGF-like domain to receptors.
EGF-like Domain (aa 220-340): The receptor-binding region containing six conserved cysteine residues that form three disulfide bonds. This domain is necessary and sufficient for ErbB receptor activation.
Transmembrane Region (aa 400-430): Single-pass type I membrane anchor. Proteolytic cleavage occurs at this region to release the soluble active fragment.
C-terminal Cytoplasmic Domain (aa 430-720): Contains regulatory sequences and is subject to alternative splicing.
NRG3 undergoes proteolytic processing that generates active soluble fragments:
This processing allows NRG3 to function both as a membrane-bound ligand and as a diffusible growth factor.
NRG3 plays essential roles in multiple aspects of brain development:
Cortical Development: During corticogenesis, NRG3 regulates neuronal migration, differentiation, and layer formation. Expression in radial glial cells and intermediate progenitor cells suggests roles in controlling the timing and pattern of neurogenesis.
GABAergic Circuit Formation: NRG3 is critical for the development of GABAergic inhibitory circuits. It promotes the differentiation and maturation of interneurons, particularly parvalbumin-expressing (PV+) fast-spiking interneurons that are essential for cortical network oscillations and cognitive function[@kim2021].
Thalamic Patterning: NRG3 expression in the thalamus regulates thalamocortical axon guidance and the formation of precise sensory maps.
Myelination: Though NRG1 is the primary regulator of myelination, NRG3 contributes to oligodendrocyte differentiation and myelin maintenance in specific brain regions[@marafon2020].
NRG3 modulates synaptic function throughout the lifespan:
Synapse Formation: NRG3 promotes excitatory synapse formation through activation of ErbB4 in postsynaptic neurons. This involves recruitment of postsynaptic density proteins and insertion of AMPA receptors.
LTP and LTD: NRG3 signaling modulates both long-term potentiation and long-term depression. Activation of ErbB4 facilitates LTP induction, while blockade of NRG3-ErbB4 signaling impairs memory consolidation.
GABAergic Plasticity: NRG3 critically regulates inhibitory synaptic plasticity, particularly in cortical and hippocampal circuits. This function is essential for balanced excitation/inhibition that underlies proper cognitive processing.
NRG3 influences multiple cognitive domains:
Learning and Memory: NRG3-ErbB4 signaling in the hippocampus is essential for spatial learning and memory consolidation. Both gain and loss of NRG3 function impair performance on hippocampal-dependent tasks.
Attention and Executive Function: NRG3 in prefrontal cortex regulates attention processes and executive function through modulation of pyramidal neuron activity and interneuron circuits.
Social Behavior: Altered NRG3 signaling affects social interaction and social memory in animal models, consistent with its role in social cognition[@mahan2012][@patel2020].
NRG3 exhibits region-specific expression:
At the cellular level:
NRG3 is one of the most consistently implicated genes in schizophrenia:
Association Studies: Multiple GWAS have identified NRG3 variants associated with schizophrenia risk. The most prominent is a haplotype in the 5' region of the gene that affects expression.
Copy Number Variants: Duplications and deletions spanning the NRG3 locus have been reported in schizophrenia patients.
Rare Variants: Exome sequencing has identified NRG3 missense mutations that may affect protein function in a subset of patients[@wang2019].
Linkage Studies: Chromosome 10p12, where NRG3 resides, has been linked to schizophrenia in multiple family studies.
NRG3 dysfunction contributes to schizophrenia through several mechanisms:
GABAergic Dysfunction: NRG3 is essential for proper development and function of PV+ interneurons. Reduced NRG3 signaling leads to PV+ interneuron deficits that are a hallmark of schizophrenia neuropathology.
Excitation-Inhibition Imbalance: Altered NRG3 signaling disrupts the balance between excitatory glutamatergic and inhibitory GABAergic transmission, potentially contributing to neural circuit dysfunction.
Synaptic Plasticity Impairment: NRG3 modulates synaptic plasticity mechanisms that are critical for cognitive function. Deficits in these processes may underlie working memory and learning deficits in schizophrenia.
Dopaminergic Dysregulation: NRG3 influences dopaminergic system development and function. Altered NRG3 signaling may contribute to the dopaminergic dysregulation characteristic of schizophrenia.
NRG3-based therapeutic approaches for schizophrenia include:
NRG3 alterations have been reported in Alzheimer's disease:
Expression Changes: Some studies show altered NRG3 expression in AD brains, though the direction of change varies across studies and brain regions.
Genetic Association: Some evidence links NRG3 variants to AD risk, though data are less extensive than for schizophrenia.
Potential mechanisms for NRG3 involvement in AD include:
Synaptic Dysfunction: NRG3 regulates synaptic plasticity that is compromised in AD. Loss of NRG3 signaling may contribute to synaptic failure.
Amyloid Interactions: Amyloid-beta may interfere with NRG3-ErbB4 signaling, disrupting normal neuronal function.
GABAergic Deficits: As in schizophrenia, NRG3-related GABAergic dysfunction may compound AD-related inhibitory deficits.
Neuroinflammation: NRG3 modulates microglial activation and neuroinflammatory responses that are enhanced in AD[@chen2021].
NRG3 has been implicated in attention-deficit/hyperactivity disorder:
NRG3 variants have been identified in some ASD patients:
Limited evidence suggests possible NRG3 involvement in PD:
ErbB4 Agonists: Compounds that directly activate ErbB4 to bypass NRG3 deficits are under development. However, the challenge is achieving CNS penetration and receptor specificity.
ADAM Modulators: Since proteolytic shedding is required for NRG3 activity, modulators of ADAM17 and other shedding proteases could influence NRG3 availability.
Positive Allosteric Modulators: Compounds that enhance NRG3-ErbB4 signaling without directly activating the receptor.
Recombinant NRG3 Protein: Soluble NRG3 (the EGF-like domain) can be delivered systemically or directly to the brain to enhance signaling.
Gene Therapy: AAV-mediated expression of NRG3 or modified NRG3 variants with enhanced activity.
Cell Therapy: Transplantation of cells engineered to secrete NRG3 into specific brain regions.
| Partner | Interaction Type | Functional Role |
|---------|-----------------|-----------------|
| ErbB4 | Receptor binding | Primary signaling |
| ErbB3 | Low affinity binding | Heterodimerization |
| ErbB2 | Coreceptor | Signal amplification |
| ADAM17 | Protease | Proteolytic processing |
| PSD-95 | Scaffold | Synaptic localization |
| GRB2 | Adaptor | Signal transduction |
| ErbB2/ErbB4 | Receptor complex | Signaling pathway |
NRG3 activates multiple downstream signaling cascades:
PI3K/Akt Pathway: Major pathway activated by ErbB4, promoting cell survival, protein synthesis, and metabolic regulation.
MAPK/ERK Pathway: Controls cell proliferation, differentiation, and synaptic plasticity.
PLC-γ Pathway: Generates second messengers (IP3, DAG) that regulate calcium signaling and protein kinase C activation.
STAT Pathway: ErbB4 can activate STAT transcription factors, particularly STAT5, influencing gene expression.
Nrg3 intracellular domain: Can be cleaved and translocate to the nucleus, potentially regulating gene expression directly.
Phenotype: Nrg3⁻/⁻ mice show:
Phenotype: Nrg3 transgenic mice show:
Nrg3 flox mice: Allow region-specific and temporal deletion to dissect developmental versus adult functions.
Nrg3 risk allele knock-in: Mice carrying human schizophrenia-associated NRG3 variants show behavioral and neurobiological phenotypes.
Study of NRG3 employs various approaches: